ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose-ranging Study of PRX-102 in Adult Fabry Disease Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01678898
Recruitment Status : Completed
First Posted : September 5, 2012
Last Update Posted : April 19, 2016
Sponsor:
Information provided by (Responsible Party):
Protalix

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2015
  Actual Study Completion Date : January 2016